These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 6125175)

  • 1. How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.
    Man in 't Veld AJ; Schalekamp MA
    Br J Clin Pharmacol; 1982; 13(Suppl 2):245S-257S. PubMed ID: 6125175
    [No Abstract]   [Full Text] [Related]  

  • 2. On the antihypertensive mechanisms of beta-adrenoceptor antagonists in relation to intrinsic sympathomimetic activity, cardioselectivity and hydrophilicity.
    Man in't Veld AJ; Schalekamp MA
    J Pharmacol; 1983; 14 Suppl 2():69-104. PubMed ID: 6138473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the antihypertensive action of beta-adrenergic blocking drugs.
    Prichard BN; Owens CW
    Cardiology; 1980; 66 Suppl 1():1-11. PubMed ID: 6105915
    [No Abstract]   [Full Text] [Related]  

  • 5. The antihypertensive action of beta-adrenoceptor blocking agents.
    Conway J
    Arch Int Pharmacodyn Ther; 1980; Suppl():83-91. PubMed ID: 6106461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Adrenoceptor blocking drugs and hypertension.
    Buckingham RE; Hamilton TC
    Gen Pharmacol; 1979; 10(1):1-13. PubMed ID: 33100
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypotensive mechanisms of beta blockers.
    Conway J
    Eur Heart J; 1983 Jul; 4 Suppl D():43-51. PubMed ID: 6137382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenoceptor blockade and intrinsic sympathomimetic activity--relevance in the treatment of ischaemic heart disease.
    Northcote RJ; Ballantyne D
    Scott Med J; 1985 Oct; 30(4):208-15. PubMed ID: 2869581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 10 different beta-adrenoceptor antagonists on hemodynamics, plasma renin activity, and plasma norepinephrine in hypertension: the key role of vascular resistance changes in relation to partial agonist activity.
    Man in 't Veld AJ; Schalekamp MA
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S30-45. PubMed ID: 6188918
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of action of beta-blockers in hypertension.
    Amer MS
    Biochem Pharmacol; 1977 Feb; 26(3):171-5. PubMed ID: 14643
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of beta1-beta2-selectivity and intrinsic sympathomimetic activity in beta-blockers, with particular reference to antihypertensive treatment.
    Imhof P
    Adv Clin Pharmacol; 1976; 11():26-32. PubMed ID: 25568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta Adrenergic blocking drugs.
    Prichard BN; Owens CW
    Pharmacol Ther; 1980; 11(1):109-39. PubMed ID: 6107938
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-blockers and the kidney.
    Epstein M; Oster JR
    Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.
    Ades PA
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):29S-33S. PubMed ID: 2894223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological studies on the intrinsic sympathomimetic activity of the beta-adrenoceptor antagonist mepindolol.
    Beckmann R; Müller B; Schröder G; Stock G
    Arzneimittelforschung; 1986 May; 36(5):811-3. PubMed ID: 2873820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large arteries in hypertension: heterogeneous haemodynamic response to beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity.
    Simon AC; Levenson J; Pithois-Merli I
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):45S-49S. PubMed ID: 2894224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta blockers with intrinsic sympathomimetic activity.
    White WB
    Am Fam Physician; 1985 Jan; 31(1):115-8. PubMed ID: 2857059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of nebivolol.
    Janssens WJ
    J Pharm Belg; 1992; 47(4):323-7. PubMed ID: 1357130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.